Literature DB >> 12271791

Olanzapine-induced hyperventilation: case report.

S Pirzada Sattar1, David R Gastfriend.   

Abstract

Although olanzapine therapy has been associated with fewer extrapyramidal side effects than the traditional antipsychotic medications, reported side effects include dystonia, tardive dyskinesia, hypotension, diabetes mellitus, seizures and neuroleptic malignant syndrome. There are no previous published reports of hyperventilation associated with olanzapine therapy, but we present the case of a male patient who developed dyspnea and hyperventilation while taking olanzapine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12271791      PMCID: PMC161680     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  15 in total

1.  Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia.

Authors:  H A Youssef; J L Waddington
Journal:  Int Clin Psychopharmacol       Date:  1989-01       Impact factor: 1.659

2.  Adenosine receptor mediated stimulation of ventilation in man.

Authors:  B Jonzon; C Sylvén; B Beermann; R Brandt
Journal:  Eur J Clin Invest       Date:  1989-02       Impact factor: 4.686

3.  Salicylism, hyperventilation, and the central nervous system.

Authors:  J Brem; E M Pereli; S K Gopalan; T B Miller
Journal:  J Pediatr       Date:  1973-08       Impact factor: 4.406

4.  Salicylate-induced hyperventilation.

Authors:  T Ring; P T Andersen; F Knudsen; F B Nielsen
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

5.  Hyperventilation associated with quetiapine.

Authors:  P S Shelton; F L Barnett; S E Krick
Journal:  Ann Pharmacother       Date:  2000-03       Impact factor: 3.154

6.  Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

Authors:  S Leucht; G Pitschel-Walz; D Abraham; W Kissling
Journal:  Schizophr Res       Date:  1999-01-04       Impact factor: 4.939

7.  Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.

Authors:  W J Weiner; C G Goetz; P A Nausieda; H L Klawans
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

8.  Peripheral versus central cardiorespiratory effects of morphine.

Authors:  R N Willette; H N Sapru
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

9.  Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors:  K O Vollmer; A von Hodenberg; E U Kölle
Journal:  Arzneimittelforschung       Date:  1986-05

10.  Serotonin and the control of ventilation in awake rats.

Authors:  E B Olson; J A Dempsey; D R McCrimmon
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.